These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36633319)

  • 1. The role of Fusobacteria in oral cancer and immune evasion.
    Harrandah AM
    Curr Opin Oncol; 2023 Mar; 35(2):125-131. PubMed ID: 36633319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusobacterium nucleatum and oral cancer: a critical review.
    McIlvanna E; Linden GJ; Craig SG; Lundy FT; James JA
    BMC Cancer; 2021 Nov; 21(1):1212. PubMed ID: 34774023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Targeting by
    Abed J; Maalouf N; Parhi L; Chaushu S; Mandelboim O; Bachrach G
    Front Cell Infect Microbiol; 2017; 7():295. PubMed ID: 28713780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogenesis mechanisms of Fusobacterium nucleatum.
    Gholizadeh P; Eslami H; Kafil HS
    Biomed Pharmacother; 2017 May; 89():918-925. PubMed ID: 28292019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colon Cancer-Associated
    Abed J; Maalouf N; Manson AL; Earl AM; Parhi L; Emgård JEM; Klutstein M; Tayeb S; Almogy G; Atlan KA; Chaushu S; Israeli E; Mandelboim O; Garrett WS; Bachrach G
    Front Cell Infect Microbiol; 2020; 10():400. PubMed ID: 32850497
    [No Abstract]   [Full Text] [Related]  

  • 6. Fusobacterium nucleatum - symbiont, opportunist and oncobacterium.
    Brennan CA; Garrett WS
    Nat Rev Microbiol; 2019 Mar; 17(3):156-166. PubMed ID: 30546113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coaggregation of Fusobacterium nucleatum, Selenomonas flueggei, Selenomonas infelix, Selenomonas noxia, and Selenomonas sputigena with strains from 11 genera of oral bacteria.
    Kolenbrander PE; Andersen RN; Moore LV
    Infect Immun; 1989 Oct; 57(10):3194-203. PubMed ID: 2777378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of
    Fujiwara N; Kitamura N; Yoshida K; Yamamoto T; Ozaki K; Kudo Y
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Fusobacteria.
    OMATA RR; BRAUNBERG RC
    J Bacteriol; 1960 Dec; 80(6):737-40. PubMed ID: 13730937
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer invasion and anaerobic bacteria: new insights into mechanisms.
    Hurst R; Brewer DS; Gihawi A; Wain J; Cooper CS
    J Med Microbiol; 2024 Mar; 73(3):. PubMed ID: 38535967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ineffectiveness of streptomycin as a selective agent in the cultivation of oral fusobacteria.
    DE ARAUJO WC; GIBBONS RJ
    J Bacteriol; 1962 Sep; 84(3):593-4. PubMed ID: 14025667
    [No Abstract]   [Full Text] [Related]  

  • 12. Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer.
    Wang N; Fang JY
    Trends Microbiol; 2023 Feb; 31(2):159-172. PubMed ID: 36058786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular replication of fusobacteria requires new actin filament formation of epithelial cells.
    Gursoy UK; Könönen E; Uitto VJ
    APMIS; 2008 Dec; 116(12):1063-70. PubMed ID: 19133009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma.
    Kostic AD; Gevers D; Pedamallu CS; Michaud M; Duke F; Earl AM; Ojesina AI; Jung J; Bass AJ; Tabernero J; Baselga J; Liu C; Shivdasani RA; Ogino S; Birren BW; Huttenhower C; Garrett WS; Meyerson M
    Genome Res; 2012 Feb; 22(2):292-8. PubMed ID: 22009990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiota, Fusobacteria, and Colorectal Cancer.
    Kelly D; Yang L; Pei Z
    Diseases; 2018 Dec; 6(4):. PubMed ID: 30544946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological characteristics of oral fusobacteria as revealed by the electron microscope.
    HAMPP EG; SCOTT DB; WYCKOFF RW
    J Bacteriol; 1960 May; 79(5):716-28. PubMed ID: 14399384
    [No Abstract]   [Full Text] [Related]  

  • 17. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
    Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
    J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma.
    Eckert AW; Wickenhauser C; Salins PC; Kappler M; Bukur J; Seliger B
    J Transl Med; 2016 Apr; 14():85. PubMed ID: 27044404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1).
    Michikawa C; Gopalakrishnan V; Harrandah AM; Karpinets TV; Garg RR; Chu RA; Park YP; Chukkapallia SS; Yadlapalli N; Erikson-Carter KC; Gleber-Netto FO; Sayour E; Progulske-Fox A; Chan EKL; Wu X; Zhang J; Jobin C; Wargo JA; Pickering CR; Myers JN; Silver N
    Neoplasia; 2022 Sep; 31():100813. PubMed ID: 35834946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intergeneric coaggregation of oral Treponema spp. with Fusobacterium spp. and intrageneric coaggregation among Fusobacterium spp.
    Kolenbrander PE; Parrish KD; Andersen RN; Greenberg EP
    Infect Immun; 1995 Dec; 63(12):4584-8. PubMed ID: 7591109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.